FDA Must Consider UDI Rule’s Impact On mHealth, Coalition Cautions
This article was originally published in The Gray Sheet
Executive Summary
In response to an FDA proposal that would require unique device identifiers to improve post-market surveillance of medical technologies, the mHealth Regulatory Coalition argues that most mobile health apps should fall under exceptions to the rule.